powered help
header-left header-center header-right
File #: 221702    Version: 0
Type: Resolution-Immediate Adoption Status: Passed
File created: 2/28/2023 In control: COMMON COUNCIL
On agenda: Final action: 2/28/2023
Effective date:    
Title: Resolution amending the membership of the City-County Heroin, Opioid, and Cocaine Task Force.
Sponsors: ALD. MURPHY
Indexes: CITY-COUNTY HEROIN, OPIOID, AND COCAINE TASK FORCE

IMMEDIATE ADOPTION

Number

221702

Version

ORIGINAL

Reference

161061, 201701

Sponsor

ALD. MURPHY

Title

Resolution amending the membership of the City-County Heroin, Opioid, and Cocaine Task Force.

Analysis

This resolution amends the membership of the City-County Heroin, Opioid, and Cocaine Task Force by adding a representative from an area treatment center to be appointed by the chair of the City-County Heroin, Opioid, and Cocaine Task Force.

Body

Whereas, The City-County Heroin, Opioid, and Cocaine Task Force was created by Common Council File Number 161061 on January 18, 2017, for the purpose of addressing the problem of rising prevalence of opioid, heroin, synthetic analog, and cocaine (in both powder and crack form) misuse and addiction in Milwaukee and to make evidence-based recommendations to reduce fatal and nonfatal overdose within the community; and

 

Whereas, The membership of the City-County Heroin, Opioid, and Cocaine Task Force was amended by Common Council File Number 201701 on May 4, 2021; and

 

Whereas, The Task Force has determined that a representative from an area treatment center would be beneficial to the ongoing work of the Task Force; now, therefore, be it

 

Resolved, By the Common Council of the City of Milwaukee, that Common Council Resolution File Number 161061 adopted on January 18, 2017, as amended by Resolution File Number 201701, is amended by inserting Item Number 8 in the “Resolved” clause with the following:

 

“One representative from an area treatment center to be appointed by the Chair of the Task Force.”

 

Requestor

 

Drafter

LRB 177935-1

Christopher Hillard

2/23/2023